Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjiang Chen

Showing results (131-140 of 279) with videos related to

Pageof 28
Sort By:
Theranostics|June 10, 2016
Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK PathwayPengfei Ma, Yujie Fu, Minjiang Chen, et al.
Translational Lung Cancer Research|December 13, 2024
Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patientsDongming Zhang, Junping Fan, Xiaoyan Liu, et al.
Frontiers in Immunology|December 26, 2022
Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 28, 2022
Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 ResponseBufu Tang, Jinyu Zhu, Yajie Wang, et al.
Radiology|June 13, 2018
Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene TherapyJiansong Ji, Qiaoyou Weng, Feng Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 28, 2020
[Results of EGFR Mutations Detected in Pleural Effusion and Its 
Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer: 
A Retrospective Study in A Single Center]Tao Lu, Qiang Li, Lan Li, et al.
Journal of Advanced Research|October 4, 2021
Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burdenBufu Tang, Jinyu Zhu, Zhongwei Zhao, et al.
Frontiers in Oncology|April 3, 2023
Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogramYanping Su, Chenying Lu, Shenfei Zheng, et al.
ACS Nano|December 4, 2024
NIR-II Imaging for Tracking the Spatiotemporal Immune Microenvironment in Atherosclerotic PlaquesLin Shen, Minjiang Chen, Yanping Su, et al.
Ebiomedicine|October 29, 2024
Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsXinyu Liu, Bo Lu, Hao Tang, et al.
Pageof 28

Showing results (131-140 of 279) with videos related to

Sort By:
Pageof 28
Theranostics|June 10, 2016
Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK PathwayPengfei Ma, Yujie Fu, Minjiang Chen, et al.
Translational Lung Cancer Research|December 13, 2024
Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patientsDongming Zhang, Junping Fan, Xiaoyan Liu, et al.
Frontiers in Immunology|December 26, 2022
Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 28, 2022
Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 ResponseBufu Tang, Jinyu Zhu, Yajie Wang, et al.
Radiology|June 13, 2018
Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene TherapyJiansong Ji, Qiaoyou Weng, Feng Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 28, 2020
[Results of EGFR Mutations Detected in Pleural Effusion and Its 
Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer: 
A Retrospective Study in A Single Center]Tao Lu, Qiang Li, Lan Li, et al.
Journal of Advanced Research|October 4, 2021
Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burdenBufu Tang, Jinyu Zhu, Zhongwei Zhao, et al.
Frontiers in Oncology|April 3, 2023
Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogramYanping Su, Chenying Lu, Shenfei Zheng, et al.
ACS Nano|December 4, 2024
NIR-II Imaging for Tracking the Spatiotemporal Immune Microenvironment in Atherosclerotic PlaquesLin Shen, Minjiang Chen, Yanping Su, et al.
Ebiomedicine|October 29, 2024
Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsXinyu Liu, Bo Lu, Hao Tang, et al.
Pageof 28